We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$1.13B
AUM Growth
+$319M
Cap. Flow
+$340M
Cap. Flow %
30.14%
Top 10 Hldgs %
55.39%
Holding
5,820
New
1,131
Increased
1,662
Reduced
1,677
Closed
1,186

Sector Composition

Rank Sector Weight
1 Financials 2.49%
2 Industrials 2.24%
3 Healthcare 2.07%
4 Consumer Discretionary 2.05%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
426
HCA Healthcare
HCA
$87.2B
$181K 0.02%
1,990
+99
+5% +$7.93K
HK
427
DELISTED
Halcon Resources Corporation
HK
$181K 0.02%
905
+903
+45,150% +$215K
AAPL icon
428
Apple
AAPL
$4.54T
$179K 0.02%
5,700
+4,600
+418% +$147K
PAAS icon
429
Pan American Silver
PAAS
$18.2B
$179K 0.02%
20,811
+10,126
+95% +$95.3K
CNR
430
DELISTED
Cornerstone Building Brands, Inc.
CNR
$179K 0.02%
11,835
+9,938
+524% +$156K
ZIV
431
DELISTED
VelocityShares Daily Inverse VIX Medium Term ETN
ZIV
$178K 0.02%
+3,830
New +$175K
ARRY
432
DELISTED
Array Biopharma Inc
ARRY
$178K 0.02%
24,812
+16,493
+198% +$122K
KCG
433
DELISTED
KCG Holdings, Inc.
KCG
$178K 0.02%
14,433
+8,288
+135% +$108K
ACHC icon
434
Acadia Healthcare
ACHC
$2.76B
$177K 0.02%
2,255
-1,390
-38% -$100K
GRPN icon
435
Groupon
GRPN
$1.05B
$177K 0.02%
1,763
-1,332
-43% -$172K
SNY icon
436
Sanofi
SNY
$103B
$177K 0.02%
3,570
+1,764
+98% +$89.4K
WRLD icon
437
World Acceptance Corp
WRLD
$838M
$176K 0.02%
2,854
+1,641
+135% +$131K
SCLN
438
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$176K 0.02%
17,982
+17,882
+17,882% +$163K
CVE icon
439
Cenovus Energy
CVE
$55.7B
$175K 0.02%
10,914
-345
-3% -$6.01K
WSM icon
440
Williams-Sonoma
WSM
$26.9B
$175K 0.02%
4,258
+774
+22% +$30.3K
NSR
441
DELISTED
Neustar Inc
NSR
$175K 0.02%
+5,971
New +$169K
SBNY
442
DELISTED
Signature Bank
SBNY
$175K 0.02%
1,198
-622
-34% -$86.4K
NOC icon
443
Northrop Grumman
NOC
$77.1B
$174K 0.02%
1,098
-702
-39% -$112K
SID icon
444
Companhia Siderúrgica Nacional
SID
$1.31B
$174K 0.02%
105,469
+16,076
+18% +$34.4K
STT icon
445
State Street
STT
$50.6B
$174K 0.02%
2,254
+2,071
+1,132% +$161K
GG
446
DELISTED
Goldcorp Inc
GG
$174K 0.02%
10,755
-12,362
-53% -$225K
OMF icon
447
OneMain Financial
OMF
$7.2B
$173K 0.02%
3,771
+3,591
+1,995% +$174K
EV
448
DELISTED
Eaton Vance Corp.
EV
$173K 0.02%
4,411
+3,003
+213% +$124K
CHMT
449
DELISTED
Chemtura Corporation
CHMT
$173K 0.02%
6,109
+163
+3% +$4.82K
FLTX
450
DELISTED
Fleetmatics Group PLC
FLTX
$173K 0.02%
3,700
+2,916
+372% +$129K

Similar funds

Tower Research Capital (TRC)'s Q2 2015 Portfolio in Review

As of Q2 2015, Tower Research Capital (TRC) held 5,820 positions worth $1.13B, up 39% from $809M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC) deployed $340M of net new capital in Q2 2015, opening 1,131 new positions and adding to 1,662 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.

By sector, the portfolio is most concentrated in Financials at 2.5% of assets, down from 4.6% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $42.4M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2015 buy was Vanguard S&P 500 ETF: 126,017 shares worth $23.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $337M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2015 reduction was Invesco QQQ Trust, cutting an estimated $42.4M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q2 2015, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.13B portfolio in Q2 2015.
  • Tower Research Capital (TRC) opened 1,131 new positions and closed 1,186 in Q2 2015.
  • Tower Research Capital (TRC)'s portfolio value rose 39% quarter-over-quarter to $1.13B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2015, filed 30 Jul 2015.